Your session is about to expire
← Back to Search
KBL697 for Psoriasis
Study Summary
This trial will test the effectiveness and safety of KBL697, a potential new treatment for plaque psoriasis.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have long-term moderate plaque psoriasis.I haven't used tar or salicylic acid shampoos in the last 2 weeks.I have tried at least 2 treatments for plaque psoriasis without success.My psoriasis was caused by medication.I do not have other skin conditions that could affect my psoriasis assessment.I am between 18 and 75 years old.My psoriasis is not the chronic plaque type.I have been diagnosed with plaque psoriasis for at least 6 months.
- Group 1: Low dose group
- Group 2: High dose group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any available openings to join this research trial?
"According to the information hosted on clinicaltrials.gov, recruitment for this trial is ongoing. It was initially made public on November 8th 2021 and its most recent update came out of September 6th 2022."
How many individuals are engaging in this research endeavor?
"Affirmative. According to clinicaltrials.gov, recruitment is still ongoing for this experiment which was published on November 8th 2021 and has been recently amended on September 6th 2022. The research necessitates the participation of 80 patients from 6 medical centres."
How many venues provide access to this trial?
"Currently, 6 medical sites are enrolling patients in this study. These locations include Santa Ana, Birmingham and Doral among a few other places. To reduce the need for travel when taking part in the trial, it is advisable to select your closest centre."
Does this medical experiment accept applicants who are over 55 years old?
"This clinical trial requires a specific age bracket, ranging from 18 to 75 years old. There are 31 studies that cater specifically to those under the legal age of majority, and 142 for patients over 65."
Does KBL697 possess the certification of the Food and Drug Administration?
"Due to the Phase 2 nature of this trial, our evaluation yielded a safety score of two for KBL697. This indicates that there is existing evidence supporting its security but none indicating efficacy."
What criteria must a participant meet in order to be eligible for this research?
"This medical experiment is looking for 80 participants, aged between 18 to 75 years of age and currently being affected by psoriatic plaque. To be eligible, they must also fulfil the following requirements: exhibiting chronic plaque type psoriasis with a moderate severity rating and identifying as either male or female."
Share this study with friends
Copy Link
Messenger